ACM finds no competition concerns in Kyndryl's Solvinity acquisition, but investment screening bureau must still rule on national security risks before deal can proceed.
Dutch Competition Regulator Approves US…
ACM finds no competition concerns in Kyndryl's Solvinity acquisition, but investment screening bureau must still rule on national security risks before deal can proceed.